Related Experiment Videos
Oxicams: metabolic disposition in man and animals
1Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
Drug Metabolism Reviews
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Troglitazone quinone formation catalyzed by human and rat CYP3A: an atypical CYP oxidation reaction.
Biochemical pharmacology·2001
Metabolism and excretion of atorvastatin in rats and dogs.
Drug metabolism and disposition: the biological fate of chemicals·1999
Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
The Journal of pharmacology and experimental therapeutics·1999
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease.
British journal of clinical pharmacology·1998
Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
Drug metabolism and disposition: the biological fate of chemicals·1998
Bioactivation and reactivity research advances - 2025 year in review.
Drug metabolism reviews·2026
Humanized mouse models for drug metabolism and drug transport: a systematic review.
Drug metabolism reviews·2026
Drug transporters in drug disposition - highlights from the year 2025.
Drug metabolism reviews·2026
myo-Inositol's role in laying hens' active gastrointestinal microbiota: a strain comparison.
Journal of the science of food and agriculture·2026